HCA Healthcare slips -0.06 percent albeit market build-up
 | By Rifka Kats | Macroaxis Story |
Today post will go over HCA Healthcare. I will look into why albeit cyclical HCA Healthcare disturbance, the long term basic indicators of the company are still strong. This firm chance of financial distress is now about 33.0 percent. We found thirty-seven available financial indicators for HCA Healthcare which can be compared to its peers in the sector. To make sure the equity is not overpriced, please check out all HCA Healthcare fundamentals including its Profit Margin, Shares Owned by Insiders, Price to Book, as well as the relationship between Current Valuation and Number of Shares Shorted . Given that HCA Healthcare has Price to Earning of 12.22 , we strongly advise you confirm HCA Healthcare latest market performance to make sure the company can sustain itself in the coming quarters. Use HCA Healthcare to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of HCA Healthcare to be traded at $137.81 in 30 days.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Vlad Skutelnik
HCA Healthcare has beta of 0.9. HCA Healthcare returns are very sensitive to returns on the market. As market goes up or down, HCA Healthcare is expected to follow. HCA Healthcare dividends can provide a clue to current valuation of the stock. The firm one year expected dividend income is about $0.73 per share. About 21.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.29. HCA Healthcare recorded earning per share (EPS) of 10.38. The entity last dividend was issued on 2019-11-29.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as HCA Holdings. Your research has to be compared to or analyzed against HCA Holdings' peers to derive any actionable benefits. When done correctly, HCA Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in HCA Holdings.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as HCA Holdings. Regardless of method or technology, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Predictive Modules for HCA Holdings
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HCA Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
How important is HCA Holdings's Liquidity
HCA Holdings financial leverage refers to using borrowed capital as a funding source to finance HCA Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. HCA Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to HCA Holdings' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of HCA Holdings' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between HCA Holdings's total debt and its cash.
Is HCA Holdings valued fairly by the market?
The company reported last year revenue of 48.84 B. Total Income to common stockholders was 3.64 B with profit before taxes, overhead, and interest of 17.53 B. The latest bullish price patterns experienced by current HCA Healthcare shareholders may raise some interest from investors. The Stock closed today at a share price of 138.64 on 0 in trading volume. The company directors and management have been very successful with rebalancing the entity components at opportune times to take advantage of market volatility in October. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.4722. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. HCA Healthcare is selling for under 139.20. That is 0.06% down. Day Low was 138.64. HCA Healthcare Price to Earnings Ratio is somewhat stable at the moment. Moreover, HCA Healthcare Enterprise Value is decreasing over the last 4 years. To conclude, we believe that at this point HCA Healthcare is undervalued with below average probability of distress within the next 2 years. Our prevailing buy-sell advice on the company is Strong Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of HCA Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.